Drug rash with eosinophilia and systemic symptoms syndrome

Revision as of 16:50, 23 March 2016 by Kxl328 (talk | contribs)

Background

  • Known as "DRESS" syndrome
  • A severe adverse drug reaction
  • Usually begins within 8 weeks of starting a new drug
  • 8-10% mortality
  • Previously known as Dilantin Hypersensitivity Syndrome or anti-convulsant hypersensitivity syndrome[1]
  • However, many other medications, particularly antibiotics

Associated Drugs

  • Most common
    • phenytoin
    • phenobarbital
    • carbamezapine
    • allopurinol
    • sulfa drugs
  • Others

Clinical Features

  • Fever and rash (varying; may resemble SJS) are typically first signs
  • +/- lymphadenopathy
  • liver, kidney or hematologic system involvement
    • atypical lymphocytes, thrombocytopenia
    • Despite name, eosinophilia only in ~30% of cases

Differential Diagnosis

  • SJS/TENS
  • Kawasaki Disease
  • TTP
  • See Rashes

Workup

  • CBC with diff
  • BMP
  • Biopsy (as inpt)

Management

  • Discontinue suspected drug
  • Supportive care: anti-pyretic, anti-puritic
  • Systemic steroids in severe cases (controversial)
    • hepatitis, pneumonitis, extensive exfoliative dermatitis
  • Family counseling as possible genetic component

Disposition

Admit

See Also

Sources

Tintinalli 7th ed p1617-1618
http://emedicine.medscape.com/article/1049474-overview
http://www.medscape.com/viewarticle/738548_4

  1. Herbert M. EM:RAP Board Review Answers: February 2015. February 2015: Volume 15, Issue 2. www.emrap.org.